glp 1 physiology informs the pharmacotherapy of obesity GLP-1 agonists and exercise: future lifestyle prioritization Treatment of Hypothalamic Obesity With

Tang and Hazen, 2017)

Recently presented at the ILADS medical conference, human clinical research demonstrated that Researched Nutritionals' Tri-Fortify promotes healthy red blood cell glutathione levels & natural killer cell function

Enzyme-activatable polymer-drug conjugate augments tumour penetration and treatment efficacy

Troglitazone has several recognized therapeutic properties as a hypoglycemic agent, an antioxidant, a vasodilator agent, an anticonvulsant, an anticoagulant, a platelet aggregation inhibitor, an antineoplastic agent, an EC 6.2.1.3 (long-chain-fatty-acid--CoA ligase) inhibitor and a ferroptosis inhibitor (National Center for Biotechnology Information, 2023h)